Maryam A. Alahmad

Abu Dhabi, AZ, United Arab Emirates

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Postoperative Complications Associated with Advanced Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.

Postoperative Complications Associated with Advanced Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.

Journal: Advances in therapy

Published: July 05, 2026

Real-world outcomes of subcutaneous infliximab in a Middle Eastern inflammatory bowel disease cohort: a prospective study of switch and de novo treatment strategies.

Real-world outcomes of subcutaneous infliximab in a Middle Eastern inflammatory bowel disease cohort: a prospective study of switch and de novo treatment strategies.

Journal: Crohn's & colitis 360

Published: March 01, 2026

Real-world effectiveness of guselkumab for induction of remission in Crohn's disease: a prospective multicenter cohort study with propensity score-matched comparison to risankizumab.

Real-world effectiveness of guselkumab for induction of remission in Crohn's disease: a prospective multicenter cohort study with propensity score-matched comparison to risankizumab.

Journal: Crohn's & colitis 360

Published: February 20, 2026

Paradigm shift in inflammatory bowel disease management-advanced therapy utilization, persistence, and outcomes in a United Arab Emirates cohort during 2015-2025.

Paradigm shift in inflammatory bowel disease management-advanced therapy utilization, persistence, and outcomes in a United Arab Emirates cohort during 2015-2025.

Journal: Crohn's & colitis 360

Published: December 30, 2025

Incidence of acne in patients with inflammatory bowel disease treated with Janus kinase inhibitors: a systematic review and meta-analysis.

Incidence of acne in patients with inflammatory bowel disease treated with Janus kinase inhibitors: a systematic review and meta-analysis.

Journal: Inflammatory bowel diseases

Published: November 04, 2025

Utilisation and real-world effectiveness of advanced therapies for inflammatory bowel disease in Middle Eastern populations: a systematic review.

Utilisation and real-world effectiveness of advanced therapies for inflammatory bowel disease in Middle Eastern populations: a systematic review.

Journal: BMJ open gastroenterology

Published: August 12, 2025

Real-World Effectiveness of Risankizumab in Crohn's Disease: Outcome Data for an IL-23 Inhibitor from the Middle East.

Real-World Effectiveness of Risankizumab in Crohn's Disease: Outcome Data for an IL-23 Inhibitor from the Middle East.

Journal: Crohn's & colitis 360

Published: July 14, 2025

Effectiveness of AI-enhanced colonoscopy: A case-control study using real world evidence in a young screening age population.

Effectiveness of AI-enhanced colonoscopy: A case-control study using real world evidence in a young screening age population.

Journal: Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association

Published: June 28, 2025

Assessing the unique concerns of Arab patients with inflammatory bowel disease: A cross-sectional study and the case for region-specific support groups.

Assessing the unique concerns of Arab patients with inflammatory bowel disease: A cross-sectional study and the case for region-specific support groups.

Journal: Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association

Published: May 25, 2025

First Case Report of Bilateral Avascular Necrosis in an Eosinophilic Esophagitis Patient on Swallowed Fluticasone.

First Case Report of Bilateral Avascular Necrosis in an Eosinophilic Esophagitis Patient on Swallowed Fluticasone.

Journal: Cureus

Published: October 31, 2024

Letter: Early real-world evidence from the United Arab Emirates of the persistence, effectiveness and safety of risankizumab for the treatment of Crohn's disease.

Letter: Early real-world evidence from the United Arab Emirates of the persistence, effectiveness and safety of risankizumab for the treatment of Crohn's disease.

Journal: Alimentary pharmacology & therapeutics

Published: May 03, 2024

Factors Associated With Delayed Gastric Emptying in Symptomatic Diabetic and Non-diabetic Patients: A Retrospective Observational Study.

Factors Associated With Delayed Gastric Emptying in Symptomatic Diabetic and Non-diabetic Patients: A Retrospective Observational Study.

Journal: Cureus

Published: April 11, 2024

Showing 1-12 of 14

Last Updated: 09/26/2026